Work

Comparative risk of interstitial lung disease (ILD) among Trastuzumab Deruxtecan (T-DXd) and other anti-breast cancer drugs: a VigiBase pharmacovigilance study approach.

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa1565

Authors: Kevin Bihan, Lana Elu, Anthony Canellas, Marc-Antoine Benderra, Paul Gougis, Joseph Gligorov, Bénédicte Lebrun-Vignes, Jacques Cadranel, Lana Elu

Institutions: Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Sorbonne Université, Hôpital Tenon, Inserm, Groupe de REcherche en Cardio Oncologie

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404101254

Cites:

Cited by:

Related to: 10